PDF) WTX101 in patients newly diagnosed with Wilson disease: final

PDF) WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial

PDF) Benefits and drawbacks of current copper chelators in Wilson disease

Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease

Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. - Abstract - Europe PMC

Table 4 from EASL Clinical Practice Guidelines: Wilson's disease.

Wilson Disease in Infancy through Adolescence - ScienceDirect

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

History of Wilson Disease - ScienceDirect

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

PDF) Benefits and drawbacks of current copper chelators in Wilson disease

PDF) Wilson's Disease: An Update on the Diagnostic Workup and Management

Wilson's disease